Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
8
×
life sciences
8
×
national blog main
national top stories
boston blog main
biotech
boston top stories
san francisco blog main
clinical trials
national
new york blog main
san francisco top stories
texas blog main
texas top stories
boston
fda
foundation medicine
blueprint medicines
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
companion diagnostic
crispr
detroit blog main
detroit top stories
editas medicine
indiana blog main
indiana top stories
keytruda
new york top stories
precision medicine
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
What
medicine
8
×
cancer
drug
fda
patients
tumor
genetic
market
morning
new
risks
series
acquire
agent
agreed
allison
announced
approval
approved
benefiting
better
big
billion
blueprint
boston
broad
cancers
cas
cells
chasing
coming
confidence
countless
crispr
dallas
deadly
deciphera
deeper
defect
developing
Language
unset
Current search:
medicine
×
cancer
×
" life sciences "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
5 years ago
OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 Million